INVELTYS

NDA 210565 · New Drug Application (NDA) Discontinued

LOTEPREDNOL ETABONATE

Sponsor (Drugs@FDA)
ALCON LABS INC Company: ALCON INC (ALC)
First approved
Latest action

Drugs on HealthTrade

No drug on HealthTrade cites this application. Novel approvals since 2015 by healthcare companies HealthTrade covers are listed from Drugs@FDA automatically, labelled “Not yet reviewed”; editors link the others.

Products

Drugs@FDA products under NDA 210565, with Orange Book listing details
ProductName and ingredientForm and strengthMarketing statusTE codeReferenceOrange Book
001 INVELTYS LOTEPREDNOL ETABONATE SUSPENSION/DROPS;OPHTHALMIC 1%Discontinued– Reference listed drug RXApproved

Submissions

FDA submissions for NDA 210565, newest first
SubmissionStatusStatus dateReviewClassDocuments
Supplement 3ApprovedstandardLabelingLetter for Supplement 3 (opens in a new tab)Label for Supplement 3 (opens in a new tab)
Original 1ApprovedstandardType 5 - New Formulation or New ManufacturerLetter for Original 1 (opens in a new tab)Label for Original 1 (opens in a new tab)

Orange Book patents

14 patents listed, as the Orange Book prints them.

Orange Book patents for NDA 210565
PatentExpiresClaimsUse codeSubmitted
10058511Product 001 Drug product U-2492
10646437Product 001 Drug product –
10688045Product 001 Drug product –
10864219Product 001 Method of use U-3011
11219597Product 001 Method of use U-3278
11219597Product 001 Method of use U-3279
11642317Product 001 Drug product –
11872318Product 001 Drug product –
12115246Product 001 Drug product U-4025
9056057Product 001 Drug product U-2491
9393213Product 001 Drug product –
9532955Product 001 Method of use U-2491
9737491Product 001 Method of use U-2492
9827191Product 001 Drug product U-2493

Orange Book exclusivities

No Orange Book exclusivities are listed for this application.

Prescription labels

No human prescription label in openFDA cites this application.

NDC products

No NDC directory product carries this application number.

FDA recalls load here.

FDA drug shortages load here.

Sources

Data provided by the U.S. Food and Drug Administration. Showing it here is not an FDA endorsement. openFDA asks: “Do not rely on openFDA to make decisions regarding medical care.”

Patent and exclusivity dates are as FDA lists them and can change. Nothing on this page is medical or investment advice.